Therefore, the use of IDO inhibitors, such as 1-MT, or epigallocatechin gallate in the animal models suppressed the occurrence of colonic preneoplastic lesions and reduced tumor size and mortality in animals with cancer (Figure 3) [63,98,99,163]. The gene discussed is IDO1; the disease is cancer.